The name thalassemia has a historical connection to the Mediterranean Sea. Because many early patients were of Mediterranean descent, Whipple called the disorder Thalassic anemia, with “Thalassic” meaning “great sea” in Greek. The name was later changed to thalassemia.
How Did the Name Develop?
In 1925, Cooley and Lee described four children with anemia, an enlarged spleen, mild liver enlargement, and facial bone changes. These findings later became recognized as typical of untreated β-thalassemia major, often called Cooley’s anemia.
Seven years later, Whipple and Bradford published detailed autopsy studies of children who had died of the disorder. Its frequent occurrence among patients of Mediterranean descent influenced the sea-related name.
REMEMBER
The Mediterranean connection explains the name, not the cause.
Thalassemias are inherited disorders involving reduced or absent production of one or more globin chains. This decreases hemoglobin production and leaves excess unpaired chains that can damage red blood cells or their precursors.
Why This Matters in MedTech
Keep the terms distinct: thalassemia refers to a group of disorders, while Cooley’s anemia refers specifically to β-thalassemia major.
Reference
Rodak’s Hematology: Clinical Principles and Applications. 7th edition. “Definitions and History” section.


